BeOne Medicines Completes Key Sonrotoclax Formulation Study, Trimming Early-Stage Risk
at www.tipranks.com (Fri, 23-Oct 12:30 PM)
ONC and Revolution Medicines Forge Key Deal: Exclusive RAS(ON) Inhibitor Rights in Asia and Combination Trials Shape Future Oncology Roadmap
Market Chameleon (Mon, 10-Aug 7:08 AM)
BeOne Medicines Raises 2026 Revenue Guidance After Brukinsa’s Strong Global Growth and Pipeline Advancements
Market Chameleon (Wed, 5-Aug 7:39 AM)
